Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
screening for reproductive / developmental toxicity
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2009
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009
Report date:
2009

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
Version / remarks:
adapted by the Council on 27th July 1995
GLP compliance:
yes (incl. QA statement)
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2,2`-[6-(phenylamino)-1,3,5-triazine-2,4-diyl]diphenol
Cas Number:
1248-66-4
Molecular formula:
C21H16N4O2
IUPAC Name:
2,2`-[6-(phenylamino)-1,3,5-triazine-2,4-diyl]diphenol

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Harlan Laboratories Ltd. Laboratory Animal Services Wölferstrasse 4 4414 Füllinsdorf / Switzerland
- Age at study initiation: (P) 11 weeks
- Weight at study initiation: (P) Males: 298 to 357 g; Females: 186 to 217 g
- Housing: Individually in Makrolon type-3 cages. During the pre-pairing period, cages with males
were interspersed amongst those holding females to promote the development of regular estrus cycles.
- Diet: ad libitum. Pelleted standard Kliba Nafag 3433 rodent maintenance diet (Provimi Kliba SA, 4303 Kaiseraugst / Switzerland).
- Water: ad libitum. Community tap-water from Füllinsdorf.
- Acclimation period: 7 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 30 - 70%
- Air changes (per hr): 10 - 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12-hour fluorescent light / 12-hour dark cycle with music during the light period

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
polyethylene glycol
Remarks:
PEG 300
Details on exposure:
The dose formulations were prepared weekly; addition of 80% PEG 300 to the substance and homogenized; dose volume of 5 ml/kg body weight with daily adjustment to the actual body weight;
Details on mating procedure:
- M/F ratio per cage: 1/1
- Length of cohabitation: 14 d
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as day 0 of pregnancy
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
HPLC/UV-detection
Duration of treatment / exposure:
mailes: 14-day pre-pairing period, pairing period + 1 day; minimum 4 weeks
females: 14-day pre-pairing period, pairing period, gestation, lactation period up to day 4 post partum; approximately 7 weeks;
Frequency of treatment:
once daily orally by gavage
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
50 mg/kg body weight/day
Basis:
actual ingested
Remarks:
Doses / Concentrations:
200 mg/kg body weight/day
Basis:
actual ingested
Remarks:
Doses / Concentrations:
1000 mg/kg body weight/day
Basis:
actual ingested
No. of animals per sex per dose:
10
Control animals:
yes, concurrent vehicle
Details on study design:
- Dose selection rationale: The dose levels were selected based on a previous short term study (RCC No. B31972) performed at Harlan Laboratories Ltd. (former RCC Ltd).
- Rationale for animal assignment (if not random):
- Fasting period before blood sampling for clinical biochemistry:
- Other:

Examinations

Parental animals: Observations and examinations:
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: once daily;

BODY WEIGHT: Yes
- Time schedule for examinations: daily

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes

Sperm parameters (parental animals):
The testes and epididymides of all parental males were weighed as pairs. In addition, adrenal glands and thymus were weighed in males.
Litter observations:
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
external examination at first Litter Check and a last litter check (day 4); clinical signs and macroscopic findings; number and sex of pups, stillbirths, live births, postnatal mortality, weight gain to day 4 post partum;

Postmortem examinations (parental animals):
SACRIFICE
- Male animals: All animals after pairing period
- Maternal animals: All animals on day 4 post partum
Statistics:
The following statistical methods were used to analyze food consumption, body weights and reproduction data:
• Means and standard deviations of various data were calculated.
• The Dunnett-test (many to one t-test) based on a pooled variance estimate was applied if the variables could be assumed to follow a normal distribution for the comparison of the treated groups and the control groups for each sex.
• The Steel-test (many-one rank test) was applied instead of the Dunnett-test when the data could not be assumed to follow a normal distribution.
• Fisher's exact-test was applied to the macroscopical findings.

Results and discussion

Results: P0 (first parental generation)

General toxicity (P0)

Clinical signs:
effects observed, treatment-related
Description (incidence and severity):
clinical signs considered to be incidental
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Organ weight findings including organ / body weight ratios:
no effects observed
Histopathological findings: non-neoplastic:
effects observed, treatment-related
Description (incidence and severity):
adrenocortical changes consisting of minimal hypertrophic changes of the zona fasciculate at 200 mg/kg/day ; at 200 and 1000 mg/kg/day, erythropoiesis at minimal degree was noted in two females in each group.
Other effects:
no effects observed

Reproductive function / performance (P0)

Reproductive function: oestrous cycle:
no effects observed
Reproductive function: sperm measures:
no effects observed
Reproductive performance:
no effects observed

Details on results (P0)

CLINICAL SIGNS AND MORTALITY (PARENTAL ANIMALS):
All animals survived

BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS):
At all dose-levels, there were no treatment-related effects;

REPRODUCTIVE Data (PARENTAL ANIMALS):
At all dose-levels, there were no treatment-related effects on precoital time, mean duration of gestation, number of corpora lutea and implantaions, post-implantation loss, pup survival or litter size from birth through to scheduled sacrifice an day 4 post partum;

ORGAN WEIGHTS (PARENTAL ANIMALS)
No test item related changes were noted in mean organ weight of thymus, adrenals, testes and epididymides in males;

In males and females at 200 mg/kg/day and in females at 1000 mg/kg/day, adrenocortical changes consisting of minimal to moderate hypertrophic changes of the zona fasciculate were noted.

Effect levels (P0)

open allclose all
Dose descriptor:
NOAEL
Effect level:
1 000 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: with respect to reproduction/ developement toxicity;
Dose descriptor:
NOEL
Effect level:
50 mg/kg bw/day
Based on:
test mat.
Sex:
male
Basis for effect level:
other: based on the higher locomotor activity;
Dose descriptor:
NOEL
Effect level:
50 mg/kg bw/day
Based on:
test mat.
Sex:
female
Basis for effect level:
other: based on erithropoieseis noted during the histopathology examination;

Results: F1 generation

General toxicity (F1)

Clinical signs:
no effects observed
Mortality / viability:
no mortality observed
Body weight and weight changes:
no effects observed
Sexual maturation:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
effects observed, non-treatment-related
Histopathological findings:
effects observed, non-treatment-related

Details on results (F1)

no findings regarding first litter check and last last litter check (day 4), clinical signs and macroscopic findings in all groups;

Effect levels (F1)

Dose descriptor:
NOAEL
Generation:
F1
Effect level:
1 000 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: fetal toxicity

Overall reproductive toxicity

Reproductive effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
NOEL (reproduction/developmental toxicity) = 1000 mg/kg bw/day
Executive summary:

The reproductive toxicity of the substance was evaluated in an experimental study performed according to the OECD Guideline 421.
Test item was administered in Milli-Q-Water as vehicle at dosages of 50, 200, and 1000 mg/kg body weight/day, and controls received the vehicle only. Test item was administered to male rats for at least 28 days and to female rats for 15 days prior to pairing, through the pairing and gestation periods until the F1 generation reached day 4 post partum.
All animals survived until the scheduled necropsy and no test item-related clinical signs were noted during the study. Food consumption and body weight were not affected by the treatment with the test item. At 1000 mg/kg/day locomotor activity resulted to be increased in males.
The reproduction and developmental parameters investigated did not give any indication of any
test item-related effects. The weight of thymus, adrenals, testes and epididymides were not affected by the treatment with the test item. At histopathology examination, an increased erythropoiesis was noted in females at 200 and 1000 mg/kg/day.


Based on the increased locomotor activity in males and on the increased erithropoiesis in females, the general NOEL (No Observed Effect Level) was considered to be 50 mg/kg body weight/day.
Under the conditions of this study, the NOAEL (No Observed Effect Level) for reproduction/developmental toxicity was considered to be 1000 mg/kg/day.